News
Ophthalmology Times connects eye care professionals with surgery, imaging, gene therapy, & diagnostic advances to enhance ...
Thyroid eye disease (TED) is an autoimmune condition that affects the eyes. When Graves' illness progresses to TED, the ...
Viridian Therapeutics reveals promising long-term results for veligrotug in treating thyroid eye disease, highlighting its ...
In patients with active or chronic thyroid eye disease, veligrotug improved symptoms of proptosis and diplopia and clinical ...
Veligrotug demonstrated strong long-term durability and efficacy in Phase 3 THRIVE trials for thyroid eye disease, meeting ...
Batoclimab In TED Might Offer Additional Proof-Of-Concept Of Anti-FcRn Targeting Immunovant is in the process of developing batoclimab for the treatment of patients with Thyroid Eye Disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results